EUDA Health partners with Guangdong Cell Biotech

EUDA Health (EUDA) announced an update to the potential strategic partnership, previously announced in December 2024, with Guangdong Cell Biotech. Guangdong Cell Biotech is a prominent player in stem cell therapies and regenerative medicine in China. It develops autologous cell treatments and tailored medicines for various disorders. Instead of the initially contemplated joint venture, the parties have adopted a commercial distribution arrangement structure that better aligns with their respective operational models and regional market dynamics. “This commercial distribution structure showcases our strategy to diversify our business and revenue streams,” said Alfred Lim, CEO of EUDA. “Combining our mission to expand access to holistic healthcare solutions in Southeast Asia with Guangdong Cell Biotech’s established stem cell therapies, we aim to transform the health and wellness landscape in the region.”